Harmony Biosciences Holdings (HRMY) Capital Expenditures (2019 - 2025)
Harmony Biosciences Holdings' Capital Expenditures came in at $107,000 for Q4 2025, down 79.1% from $513,000 a year earlier but up 50.7% from the prior quarter.
Powered by 
Analysis
Harmony Biosciences Holdings (HRMY) Capital Expenditures (2019 - 2025) Analysis & Trends
For FY2025, Harmony Biosciences Holdings' Capital Expenditures was $310,000, down 73.1% from FY2024.
- Capital Expenditures carries a five-year compound annual growth rate of 174.2% (FY2020 to FY2025).
- Going back by year, Capital Expenditures was $1.15 million in FY2024 (+269.6%), $312,000 in FY2023 (+81.4%), $172,000 in FY2022 (-42.3%) and $298,000 in FY2021.
- The five-year range for quarterly Capital Expenditures is $3,000 (Q3 2024) to $632,000 (Q2 2024).
- Business Quant data shows HRMY's Capital Expenditures at $71,000 (Q3 2025), $4,000 (Q2 2025) and $128,000 (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 3.18 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 301.00 Mn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 1.04 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | -3.30 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 587.00 Mn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 237.00 Mn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 573.00 Mn |
| 10 | Harmony Biosciences Holdings | 1.97 Bn | -881.81 Mn | 188.23 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 107,000.00 |
| Sep 30, 2025 | 71,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Mar 31, 2025 | 128,000.00 |
| Dec 31, 2024 | 513,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 632,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Dec 31, 2023 | 107,000.00 |
| Sep 30, 2022 | 86,000.00 |
| Jun 30, 2022 | 41,000.00 |
| Mar 31, 2022 | 45,000.00 |
| Sep 30, 2021 | 93,000.00 |
| Jun 30, 2021 | 201,000.00 |
| Mar 31, 2021 | 4,000.00 |
| Dec 31, 2019 | 36,000.00 |
API Access
Harmony Biosciences Holdings Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=HRMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "HRMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=HRMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();